Summary: This is a published study protocol, not a completed trial, so no efficacy results are reported. It describes a planned single-centre randomised controlled trial in which 100 community-dwelling prefrail older adults with diabetes will be allocated 1:1 to a 16-week COM-B-based multicomponent exercise intervention or to usual diabetes care plus general physical-activity advice, with frailty status as the primary outcome assessed at baseline, week 8 and week 16.
PICO Summary
| Element | Detail |
|---|---|
| Population | Planned n = 100 community-dwelling prefrail older adults with diabetes; single-centre randomised controlled trial (protocol), China (Chongqing); registry ChiCTR2400082831. |
| Intervention | 16-week multicomponent exercise programme based on the Capability, Opportunity, Motivation-Behaviour (COM-B) model; planned intervention arm n = 50. |
| Comparison | Usual diabetes care plus general advice on physical activity; planned control arm n = 50. |
| Outcome | No results reported (protocol). Primary outcome: frailty status. Secondary outcomes: physical function, quality of life, depressive symptoms, self-efficacy for exercise and fasting blood glucose. Assessments planned at baseline, week 8 and week 16. No effect estimates, confidence intervals, p values, ARR or NNT are available, as the trial has not yet been conducted. |
Expert Commentary
This publication is a study protocol, and that distinction governs how it should be read. No participants have been analysed and no outcomes have been measured, so any statement that the intervention improved frailty or physical function would be unsupported. What is offered is a clearly specified design: a 1:1 randomised allocation of 100 prefrail older adults with diabetes to a 16-week multicomponent exercise programme structured around the COM-B behaviour-change framework or to usual care, with frailty status as the pre-registered primary outcome. The protocol is prospectively registered, which is reassuring for later interpretation. The principal limitation is that this is a single-centre trial with a modest planned sample, so even a successful result may not generalise widely and could be underpowered for secondary endpoints such as fasting glucose. The behavioural framing is sensible, because adherence, not physiology, is usually what limits exercise interventions in this group. Can I use this with my patients? Not yet. There is nothing here to act on clinically; it is a plan, and prefrailty management should continue to follow existing exercise and lifestyle guidance. The value of flagging it now is anticipatory. When the results appear, readers should look for the registered primary outcome, an intention-to-treat analysis and honest reporting of dropout before drawing any conclusion about benefit.
References
Wang WX, Qiu J, Kong LN, Yang J, Chen L, Zhao Y, Wang TT. Effects of an exercise intervention based on the COM-B model among community-dwelling prefrail older adults with diabetes: study protocol for a randomised controlled trial. BMJ Open. 2025;15(6):e098945. doi:10.1136/bmjopen-2025-098945
